Merck & Co Raises FY2026 Adj EPS Guidance from $5.00-$5.15 to $5.04-$5.16 vs $5.11 Est; Raises FY2026 Sales Guidance from $65.500B-$67.000B to $65.800B-$67.000B vs $66.614B Est.

Merck & Co (NYSE:MRK) raises FY2026 Adj EPS guidance from $5.00-$5.15 to $5.04-$5.16 vs $5.11 analyst estimate. Raises FY2026 sales outlook from $65.500 billion-$67.000 billion to $65.800 billion-$67.000 billion vs $66.614 billion estimate.